Silence Therapeutics
Price & Volume
Stats
See moreOpen | $19.79 |
Previous Close | $19.78 |
Day Range | $19.79-$19.80 |
52W Range | $4.19-$19.86 |
Market Cap | $1.2B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $615,000 |
Revenue Growth (YoY) | 197.2% |
Gross Profit (12 Mos) | $528,000 |
Diluted EPS | -$1.29 |
News
See moreYahoo Finance • 11 days ago
Key deals this week: Visa, London Stock Exchange, Tradeweb Markets, Salesforce, and more
Yahoo Finance • 16 days ago
Is Silence Therapeutics (NasdaqGM:SLN) Reasonable Near Its $20 Deal Price?
Yahoo Finance • 16 days ago
Silence Therapeutics (SLN) Gets 130% Premium Offer From Merck, Shares Surge Over 100%
Yahoo Finance • 16 days ago
Merck KgaA Is Paying More Than Double for This Gene-Silencing Biotech, Which Is Soaring 125%
About
CEO | Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D |
CFO | Ms. Rhonda L. Hellums |
Address | 12 Hammersmith Grove, London, United Kingdom, W6 7AP |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 88 |